Influence of the angiotensin II type 1 receptor gene polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals

Hypertension

Volumn 28, Issue 6, 1996, Pages 1081-1084

  Benetos, Athanase ^a   Cambien, François ^b   Gautier, Sylvie ^a   Ricard, Sylvain ^b   Safar, Michel ^a   Laurent, Stephane ^a   Lacolley, Patrick ^a   Poirier, Odette ^b   Topouchian, Jirar ^c   Asmar, Roland ^c  

^a HÔPITAL BROUSSAIS   (France)

^b INSERM   (France)

^c Inst Rech Form Cardiovasculaire   (France)

Author keywords

angiotensin converting enzyme inhibitors; aorta; calcium channel blockers; genetics; renin angiotensin system

Indexed keywords

ANGIOTENSIN RECEPTOR; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DNA; NITRENDIPINE; PERINDOPRIL;

ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; AORTA; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DNA POLYMORPHISM; FEMALE; GENOTYPE; HEART RATE; HOMOZYGOTE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSE WAVE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RIGIDITY; SYSTOLIC BLOOD PRESSURE;

EID: 10544228945     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.28.6.1081     Document Type: Article

References (12)

1. Albaladejo P, Bouaziz H, Duriez M, Gohlke P, Levy B, Safar M, Benetos A. Angiotensin converting enzyme inhibition prevents the increase in aortic collagen in rats. Hypertension. 1994;23:74-82.
2. Shimamoto H, Shimamoto Y. Lisinopril improves aortic compliance and renal blood flow: comparison with nitrendipine. Hypertension. 1995;25:327-334.
3. Kool MJ, Lustermans FA, Breed JG, Struijycker-Boudier HA, Hoeks AP, Reneman RS, Van Bortel LM. The influence of perindopril and the diuretic combination amiloride+hydrochlorothiazide on the vessel wall properties of large arteries in hypertensive patients. J Hypertens. 1995;13:839-848.
4. Dzau VJ, Safar ME. Large conduit arteries in hypertension: role of the renin-angiotensin system. Circulation. 1988;77:947-953.
5. Benetos A, Gautier S, Ricard S, Topouchian J, Asmar R, Poirier O, Larosa E, Guize L, Safar M, Soubrier F, Cambien F. Influence of angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients. Circulation. 1996;94:698-703.
6. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F. Angiotensin II type 1 receptor gene polymorphisms in human essential hypertension. Hypertension. 1994;24:63-69.
7. Avolio AP, Deng D, Fa-Quan D, Wei-Qiang L, Yao-Fei L, Zhen-Dong H, Lian-Fen X, O'Rourke MF. Effects of aging on arterial distensibility in populations with high and low prevalence of hypertension: comparison between urban and rural communities in China. Hypertension. 1985;71:202-210.
8. Asmar R, Benetos A, London G, Hugue C, Weiss Y, Topouchian J, Laloux B, Safar M. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Pressure. 1995;4:48-54.
9. Atlas SA, Niarchos AP. Inhibitors of the renin-angiotensin system, effects on blood pressure, aldosterone secretion and renal function. Am J Nephrol. 1983;3:118-127.
10. Bidiville J, Nussberger J, Waeber G, Porchet M, Waeber B, Brunner HR. Individual responses to converting enzyme inhibitors and calcium antagonists. Hypertension. 1988;11:166-173.
11. Witteman JCM, Grobbee DE, Valkenburg HA, van Hemert AM, Stijnen T, Burger H, Hoffman A. J-shape relation between change in diastolic blood pressure and progression of aortic atherosclerosis. Lancet. 1994;343:504-507.
12. Madhavan S, Ooi WL, Cohen H, Alderman MH. Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension. 1994;23:395-401.